Advisory Alpha LLC Sells 2,020 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Advisory Alpha LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 47.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 2,242 shares of the healthcare conglomerate's stock after selling 2,020 shares during the period. Advisory Alpha LLC's holdings in UnitedHealth Group were worth $1,175,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of UNH. Western Pacific Wealth Management LP grew its stake in shares of UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock worth $456,000 after acquiring an additional 19 shares in the last quarter. Richwood Investment Advisors LLC boosted its position in UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares during the period. Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after purchasing an additional 20 shares during the period. 44 Wealth Management LLC boosted its position in UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock worth $662,000 after purchasing an additional 21 shares during the period. Finally, Prentice Wealth Management LLC boosted its position in UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock worth $1,278,000 after purchasing an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research reports. Wolfe Research dropped their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Robert W. Baird dropped their target price on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating for the company in a report on Wednesday, May 14th. Royal Bank of Canada dropped their price target on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Finally, Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $428.43.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director John H. Noseworthy purchased 300 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the acquisition, the director now owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

NYSE UNH traded down $4.40 during trading on Tuesday, hitting $300.32. 7,055,725 shares of the company's stock were exchanged, compared to its average volume of 10,815,417. The company has a market cap of $272.43 billion, a PE ratio of 19.38, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock's 50 day moving average price is $426.60 and its two-hundred day moving average price is $490.74. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the firm posted $6.91 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.